We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Gerdau
GGB
$9.93B
| $6.38M | 0.01% |
1,579,741
+993,141
| +169% | +$4.41M |
|
1227
ALX Oncology
ALXO
$277M
| $6.36M | 0.01% |
3,071,496
-685,720
| -18% | -$1.23M |
|
|
EQPT
1228
EquipmentShare.com Inc
EQPT
$4.92B
| $6.35M | 0.01% |
322,954
+2,792
| +0.9% | +$59.8K |
|
1229
Parsons
PSN
$5.08B
| $6.34M | 0.01% |
121,103
+50,262
| +71% | +$2.71M |
|
1230
Bio-Techne
TECH
$11.3B
| $6.32M | 0.01% |
89,484
-3,786
| -4% | -$204K |
|
1231
NXP Semiconductors
NXPI
$56.5B
| $6.31M | 0.01% |
+22,469
| New | +$6.19M |
|
1232
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.11B
| $6.29M | 0.01% |
225,495
| – | – |
|
1233
Integra LifeSciences
IART
$1.26B
| $6.28M | 0.01% |
349,737
+176,254
| +102% | +$2.46M |
|
1234
ICU Medical
ICUI
$4.02B
| $6.27M | 0.01% |
42,797
+16,110
| +60% | +$2.1M |
|
1235
Adaptive Biotechnologies
ADPT
$3.88B
| $6.27M | ﹤0.01% |
292,079
+205,732
| +238% | +$3.15M |
|
|
BXDC
1236
Blackstone Digital Infrastructure Trust
BXDC
$2.04B
| $6.24M | ﹤0.01% |
+288,587
| New | +$6.27M |
|
1237
Polaris
PII
$3.49B
| $6.24M | ﹤0.01% |
91,117
-140,146
| -61% | -$9.03M |
|
1238
MYR Group
MYRG
$4.49B
| $6.23M | ﹤0.01% |
12,454
-56,871
| -82% | -$23.4M |
|
1239
NeoVolta
NEOV
$231M
| $6.22M | ﹤0.01% |
1,975,423
+1,849,432
| +1,468% | +$4.69M |
|
1240
Hershey
HSY
$34.8B
| $6.22M | ﹤0.01% |
35,459
-399,531
| -92% | -$75.3M |
|
1241
AutoNation
AN
$6.92B
| $6.22M | ﹤0.01% |
33,483
-16,987
| -34% | -$3.32M |
|
1242
PUT
Snap
SNAP
$9.18B
| $6.22M | ﹤0.01% |
1,400,000
+1,399,900
| +1,399,900% | +$7.66M |
|
1243
Cerence
CRNC
$374M
| $6.17M | ﹤0.01% |
545,186
-500,023
| -48% | -$4.9M |
|
1244
EQT Corp
EQT
$34.5B
| $6.17M | ﹤0.01% |
116,068
-699,115
| -86% | -$39.2M |
|
1245
Genius Sports
GENI
$1.96B
| $6.17M | ﹤0.01% |
1,018,036
-1,020,007
| -50% | -$5.28M |
|
1246
Corebridge Financial
CRBG
$15B
| $6.17M | ﹤0.01% |
215,360
-191,918
| -47% | -$5.19M |
|
1247
Novavax
NVAX
$1.68B
| $6.15M | ﹤0.01% |
652,773
-513,424
| -44% | -$4.6M |
|
1248
Larimar Therapeutics
LRMR
$424M
| $6.14M | ﹤0.01% |
2,012,458
+1,078,994
| +116% | +$4.28M |
|
1249
CorMedix
CRMD
$638M
| $6.12M | ﹤0.01% |
779,535
+276,570
| +55% | +$2.18M |
|
1250
Western Union
WU
$2.18B
| $6.12M | ﹤0.01% |
794,555
-3,341,063
| -81% | -$28M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.